Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine with or without eltrombopag in older AML patients not eligible for intensive chemotherapy
2014-003150-13Phase 2Completed
- Sponsor
- Technische Universität Dresden
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in acute myeloid leukemia (AML) comparing Decitabine + eltrombopag with Decitabine + placebo (2 arms). Primary endpoint: Treatment change-free survival (TCFS). Started Jan 2015; status: completed.
02
Drugs
eltrombopag
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2014-003150-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003150-13.